BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30608548)

  • 1. Prevalence and clinical implications of t(11;14) in patients with amyloid light-chain amyloidosis with or without concurrent multiple myeloma.
    Kobayashi H; Abe Y; Miura D; Narita K; Kitadate A; Takeuchi M; Matsue K
    Jpn J Clin Oncol; 2019 Feb; 49(2):195-198. PubMed ID: 30608548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.
    Bryce AH; Ketterling RP; Gertz MA; Lacy M; Knudson RA; Zeldenrust S; Kumar S; Hayman S; Buadi F; Kyle RA; Greipp PR; Lust JA; Russell S; Rajkumar SV; Fonseca R; Dispenzieri A
    Haematologica; 2009 Mar; 94(3):380-6. PubMed ID: 19211640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of t(11;14) in AL amyloidosis as a marker of response when treated with a bortezomib-based regimen.
    Dumas B; Yameen H; Sarosiek S; Sloan JM; Sanchorawala V
    Amyloid; 2020 Dec; 27(4):244-249. PubMed ID: 32551974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous light chain amyloidosis with multiple myeloma: A concise review.
    Andrei M; Wang JC
    Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):71-81. PubMed ID: 30261180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AL amyloidosis: The effect of fluorescent in situ hybridization abnormalities on organ involvement and survival.
    Ozga M; Zhao Q; Benson D; Elder P; Williams N; Bumma N; Rosko A; Chaudhry M; Khan A; Devarakonda S; Kahwash R; Vallakati A; Campbell C; Parikh SV; Almaani S; Prosek J; Bittengle J; Pfund K; LoRusso S; Freimer M; Redder E; Efebera Y; Sharma N
    Cancer Med; 2021 Feb; 10(3):965-973. PubMed ID: 33347707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of oral examination in newly diagnosed multiple myeloma patients: A safe and simple way to detect light chain amyloidosis.
    Leiba M; Jarjoura S; Abboud W; Nagler A; Yahalom R; Duek A; Yarom N
    Oral Dis; 2018 Oct; 24(7):1343-1348. PubMed ID: 29791070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of Plasmin-α2-plasmin Inhibitor Complex Predicts the Diagnosis of Systemic AL Amyloidosis in Patients with Monoclonal Protein.
    Ishiguro K; Hayashi T; Yokoyama Y; Aoki Y; Onodera K; Ikeda H; Ishida T; Nakase H
    Intern Med; 2018 Mar; 57(6):783-788. PubMed ID: 29021469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
    Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
    Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venetoclax monotherapy induced rapid and sustained response in a frail patient with refractory AL amyloidosis: Less is more?
    Yip PL; Lau JSM; Lam CP
    Int J Hematol; 2020 Aug; 112(2):234-237. PubMed ID: 32207051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?
    Leiba M; Duek A; Amariglio N; Avigdor A; Benyamini N; Hardan I; Zilbershats I; Ganzel C; Shevetz O; Novikov I; Cohen Y; Ishoev G; Rozic G; Nagler A; Trakhtenbrot L
    Genes Chromosomes Cancer; 2016 Sep; 55(9):710-8. PubMed ID: 27152944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant.
    Chang H; Sloan S; Li D; Zhuang L; Yi QL; Chen CI; Reece D; Chun K; Keith Stewart A
    Br J Haematol; 2004 Apr; 125(1):64-8. PubMed ID: 15015970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Transformation' from amyloid light chain amyloidosis to symptomatic multiple myeloma.
    Rutten KHG; Raymakers RAP; Minnema MC
    Neth J Med; 2018 Jul; 76(5):249-250. PubMed ID: 30019681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens.
    Bochtler T; Hegenbart U; Kunz C; Granzow M; Benner A; Seckinger A; Kimmich C; Goldschmidt H; Ho AD; Hose D; Jauch A; Schönland SO
    J Clin Oncol; 2015 Apr; 33(12):1371-8. PubMed ID: 25779559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14).
    Bochtler T; Hegenbart U; Heiss C; Benner A; Moos M; Seckinger A; Pschowski-Zuck S; Kirn D; Neben K; Bartram CR; Ho AD; Goldschmidt H; Hose D; Jauch A; Schonland SO
    Blood; 2011 Apr; 117(14):3809-15. PubMed ID: 21310923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Myeloma Light Chain Amyloidosis Presenting as Hepatic Failure.
    Elgouhari H; Ahmed K; Niazi M; Huntington MK
    S D Med; 2018 Mar; 71(3):112-115. PubMed ID: 29991097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple myeloma associated with amyloidosis and t(1;20)(q21;q11) translocation.
    Otokida K; Yoshida H; Mizunuma Y; Yamada M; Hiramori K
    Tohoku J Exp Med; 1990 Dec; 162(4):363-5. PubMed ID: 2102567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Landscape of Cytogenetic Aberrations in Light-Chain Amyloidosis with or without Coexistent Multiple Myeloma.
    He H; Lu J; Qiang W; Liu J; Liang A; Du J
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma.
    Bochtler T; Merz M; Hielscher T; Granzow M; Hoffmann K; Krämer A; Raab MS; Hillengass J; Seckinger A; Kimmich C; Dittrich T; Müller-Tidow C; Hose D; Goldschmidt H; Hegenbart U; Jauch A; Schönland SO
    Blood Adv; 2018 Oct; 2(20):2607-2618. PubMed ID: 30327369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myeloma.
    Berghaus N; Schreiner S; Poos AM; Raab MS; Goldschmidt H; Mai EK; Salwender HJ; Bernhard H; Thurner L; Müller-Tidow C; Weinhold N; Hegenbart U; Schönland SO; Huhn S
    FEBS J; 2023 Sep; 290(17):4256-4267. PubMed ID: 37097223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The t(11;14)(q13;q32) translocation as a poor prognostic parameter for autologous stem cell transplantation in myeloma patients with extramedullary plasmacytoma.
    Shin HJ; Kim K; Lee JJ; Song MK; Lee EY; Park SH; Kim SH; Jang MA; Kim SJ; Chung JS
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):227-35. PubMed ID: 25812994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.